IRIS
PERLINI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.680
EU - Europa 3.285
AS - Asia 1.888
OC - Oceania 15
SA - Sud America 8
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 6
Totale 9.888
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.649
CN - Cina 1.792
IE - Irlanda 1.145
UA - Ucraina 565
FI - Finlandia 437
DE - Germania 327
IT - Italia 285
SE - Svezia 211
GB - Regno Unito 127
FR - Francia 61
BE - Belgio 50
RU - Federazione Russa 39
CA - Canada 30
IN - India 22
IR - Iran 22
TR - Turchia 18
AU - Australia 12
ES - Italia 10
HK - Hong Kong 8
AT - Austria 7
ID - Indonesia 7
NL - Olanda 7
SG - Singapore 7
BR - Brasile 6
JP - Giappone 5
CZ - Repubblica Ceca 3
EU - Europa 3
GR - Grecia 3
LV - Lettonia 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
RO - Romania 3
CW - ???statistics.table.value.countryCode.CW??? 2
EG - Egitto 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
IQ - Iraq 1
KR - Corea 1
MX - Messico 1
QA - Qatar 1
SL - Sierra Leone 1
TW - Taiwan 1
Totale 9.888
Salva come PNG Salva come JPEG
Città #
Chandler 1.222
Dublin 1.145
Jacksonville 726
Nanjing 549
Ashburn 289
Ann Arbor 243
Princeton 217
Nanchang 215
Lawrence 208
Wilmington 207
Shenyang 162
Hebei 160
Beijing 152
Helsinki 148
Medford 146
Changsha 132
Jiaxing 110
Boardman 90
Pavia 75
Tianjin 72
Hangzhou 67
New York 65
Milan 64
Shanghai 54
Woodbridge 51
Brussels 50
Norwalk 41
Falls Church 36
Saint Petersburg 34
Verona 29
Fairfield 27
Toronto 25
Seattle 23
Des Moines 16
Taizhou 16
Pune 15
Washington 13
Zhengzhou 12
Çanakkale 12
Auburn Hills 11
Vicenza 11
Houston 10
Jinan 10
Ningbo 10
Kunming 9
Cáceres 8
Guangzhou 7
Orange 7
Vienna 7
Rockville 6
Singapore 6
Tappahannock 6
Cambridge 5
Lanzhou 5
Leawood 5
Semarang 5
Ardabil 4
Falkenstein 4
Feira de Santana 4
Los Angeles 4
Monmouth Junction 4
Motta Visconti 4
Redwood City 4
San Francisco 4
San Genesio Ed Uniti 4
Zanjan 4
Borås 3
Bovisio Masciago 3
Brno 3
Changchun 3
Cordaleo 3
Dearborn 3
Fuzhou 3
Haikou 3
Magenta 3
Melbourne 3
Mykolayiv 3
Sacramento 3
Senago 3
Tokyo 3
Al Qatif 2
Alexandria 2
Andover 2
Bangalore 2
Berlin 2
Bientina 2
Buckinghamshire 2
Como 2
Curaçao 2
Desio 2
Elda 2
Henderson 2
Jinhua 2
Kemerovo 2
Las Vegas 2
Latisana 2
Lecco 2
London 2
Markham 2
Martinengo 2
Totale 7.168
Salva come PNG Salva come JPEG
Nome #
Treatment of chronic heart failure: an expert system advisor for general practitioners. 91
Valore prognostico della presenza di bassi voltaggi elettrocardiografici nei pazienti affetti da amiloidosi AL 85
La simulazione su manichino migliora l’abilità degli studenti di Medicina nell’auscultazione cardiaca? L’esperienza di Pavia 80
Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients 80
Effect of chronic sympatectomy in a model of rat cardiac hypertrophy: role of the extracellular matrix. 78
Fibrillazione atriale e amiloidosi cardiaca AL: un connubio intrigante 78
Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy. 76
Adenosine A1 receptor expression during the transition from compensated pressure overload hypertrophy to heart failure. 76
Simulation-guided cardiac auscultation improves medical students' clinical skills: the Pavia pilot experience 76
Remote matrix metalloproteinases activation as systemic consequence pf liver injury: the role of lung. 76
Direct renin inhibition: another weapon to modulate the renin-angiotensin system in postinfarction remodeling? 76
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide 75
Cardiac mast cells in the transition to heart failure: innocent bystanders or key actors? 75
Lobe-specific heterogeneity and matrix metalloproteinase activation after ischemia/reperfusion injury in rat livers. 74
Peripheral blood progenitor cell mobilization and collection in 42 patients with primary systemic amyloidosis 73
A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis 73
Interstitial fibrosis is blunted by chronic sympathectomy in experimental pressure-overload hypertrophy. 73
Autonomic and ventilatory components of heart rate and blood pressure variability in freely behaving rats. 71
Experience from controlled trials of physical-training in chronic heart-failure-protocol and patient factors in effectiveness in the improvement in exercise tolerance 69
Antiadrenergic effects of adenosine in pressure overload hypertrophy. 69
Adenosine 68
Functional correlates of N-terminal natriuretic peptide type B (NT-proBNP) response to therapy in cardiac light chain (AL) amyloidosis 68
Adenosine A1 and A2A receptor cross-talk during ageing in the rat myocardium 67
Lack of contribution of autonomic influences to vascular nitric oxide release? Studies in the unanesthetized rat. 67
Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats. 67
Acute haemodynamic effects of ibopamine and dopamine on isovolumic relaxation. 67
Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance 67
Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure 66
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure. 66
Adenosine mediates sustained adrenergic desensitization in the rat heart via activation of protein kinase C. 66
Effects of the chronic digoxin administration on extracellular matrix turnover in a model of cardiac hypertrophy in Guinea pigs. 65
Right ventricular function in AL amyloidosis: characteristics and prognostic implication 64
Prognostic value of depressed midwall systolic function in cardiac light-chain amyloidosis 64
Impaired diastolic function in active rheumathoid arthritis. Relationship with disease duration. 63
Reproducibility of ultrasound assessment of common carotic and femoral artery compliance and distensibility in the anesthetized rat. 62
Analisi preliminare di un sistema esperto per la diagnosi cardiologica incruenta. 61
Semplice algoritmo per la valutazione del rilasciamento isovolumetrico del ventricolo sinistro. 61
Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients 61
The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis 61
Assessment of regional myocardial performance with end-systolic pressure lenght and thickness relationships. 61
Le alterazioni della dinamica del riempimento ventricolare sinistro predicono la progressione dell'ipertrofia ventricolare sinistra verso l'insufficienza cardiaca. 60
Enhanced vascular reactivity in the sympathectomized rat: studies in vivo and in small isolated resistance arteries 59
Matrix metalloproteinases: analysis of the activity in Guinea pig cardiac hypertrophy. 59
Alterations in Early Filling Dynamics Predict the Progression of Compensated Pressure Overload Hypertrophy to Heart Failure Better than Abnormalities in Midwall Systolic Shortening 59
Ultrasonic integrated backscatter as a useful and tool to noninvasively study myocardial function and fibrosis in hypertensive heart disease 58
Dolore Toracico. 58
Unusual manifestations of disseminated neoplasia at presentation: right-sided heart failure due to a massive cardiac metastasis and autoimmune thrombocytopenia in pleomorphic rhabdomyosarcoma of the adult. 58
Lobe-specific heterogeneity and matrix metalloproteinase activation after ischemia/reperfusion injury in rat livers 58
Early Development of Metabolic Syndrome in Patients Subjected to Lung Transplantation 58
The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44 58
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 58
Nonischemic end-systolic performance. Effects of alterations in regional and global left ventricular contractility. 57
Metalloproteasi di matrice e progressiva disfunzione diastolica del cuore ipertrofico. 57
Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis 57
Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy 57
Lung Matrix Metalloproteinase Activation following Partial Hepatic Ischemia/Reperfusion Injury in Rats 57
Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload. 56
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 56
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 56
Contribution of the dynamic phonomechanocardiography to the valvular heart disease diagnosis: an expert system study. 55
Evidence for an intrinsic mechanism regulating the heart rate variability in the transplanted and the intact heart during submaximal dynamic exercise? 55
Confronto tra apicografia calibrata e tecniche invasive della valutazione della diastole: dati preliminari. 55
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL amyloidosis 54
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis 54
Measuring left ventricular dimensions by conductance catheter in the rabbit. 53
Prevalence and Prognostic Value of Conduction Disturbances at the Time of Diagnosis of Cardiac AL Amyloidosis 53
Modificazioni dell'impulso apicale in condizioni di sovraccarico acuto di volume. 53
Critical evaluation of pharmaco-dynamic tests for cardiovascular diagnosis: an expert system approach. 53
NT-proBNP and the risk of incident hypertension: Is change over time a better predictor than baseline value? 53
The potential advantage of omapatrilat: dual anti-fibrotic and antiinflammatory effects in one single molecule 52
Durante occlusione coronarica sperimentale la dobutamina rallenta ulteriormente la costante di tempo del rilasciamento isovolumetrico. 52
Hypertensive heart disease: diagnostic and therapeutic guidelines.Commissione congiunta Società Italiana dell'lpertensione Arteriosa; Società Italiana di Cardiologia; Associazione Nazionale Medici Cardiologi Ospedalieri. 52
Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat. 52
Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis. 52
Effects of a Bioavailable Arabinoxylan-enriched White Bread Flour on Postprandial Glucose Response in Normoglycemic Subjects 52
Dynamic right and left ventricular interaction in tne rabbit: simultaneous measurements of ventricular pressure-volume loops. 51
Determinants of respiratory sinus arrhythmia in the vagotomized rabbit. 51
Pavia senza doloreUn legame tra ospedale e territorio 51
Diagnostic and Prognostic Value of Low QRS Voltages in Cardiac AL Amyloidosis 51
Modelli matematici per lo studio del rilasciamento isovolumetrico. 51
RENIN-ANGIOTENSIN SYSTEM AND ATRIAL FIBRILLATION 51
Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy 51
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 51
Evidence for an intrinsic mechanism regulating heart rate variability in the transplanted and the intact heart during submaximal dynamic exercise? 50
Atrial Fibrillation and the Renin-Angiotensin-Aldosterone System 50
As we cannot afford to renounce to new generation echocardiography in systemic amyloidosis 50
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete response 50
Thalidomide plus intermediate-dose dexametasone is an effective but toxic treatment for patients with AL (primary) amyloydosis 50
Sympathovagal interplay in the control of overall blood pressure variability in unanesthetized rats. 49
Cost-effectiveness in Italy of preventive treatment with ramipril in patients at high risk of cardiovascular events 49
Effects of preload on regional nonischemic end-systolic performance 49
Influence of residual ischaemia on heart rate variability after myocardial infarction. 49
Valore prognostico della presenza di disturbi della conduzione cardiaca nei pazienti affetti da amiloidosi AL 49
La rilevanza diagnostica e prognostica del peptide natriuretico di tipo B (BNP) e del suo frammento N terminale (NT-proBNP) nei pazienti con amiloidosi AL e insufficienza renale 49
Infarto miocardico in età giovanile e tossicodipendenze. Revisione della letteratura ed esperienza personale. 49
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 49
Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease 49
Determinants of left ventricular mass in hypertensive heart disease: a complex interplay between volume, pressure, systolic function and genes. 48
Electrocardiographic 'strain' pattern in left ventricular hypertrophy: electrical waves or mechanical function? 48
Nitric oxide-dependent vasodilatation and the regulation of arterial blood pressure. 48
Totale 6.005
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.458
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201927 0 0 0 0 0 0 0 0 0 7 6 14
2019/20202.159 648 849 14 109 5 110 27 113 5 168 95 16
2020/20211.218 147 106 67 116 11 139 22 197 66 174 143 30
2021/20221.009 19 15 37 16 38 36 31 71 61 30 151 504
2022/20233.367 376 238 51 294 347 346 3 184 1.376 17 89 46
2023/20241.040 163 199 47 84 113 291 36 74 10 23 0 0
Totale 10.112